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Background: Surfactant treatment reduces respiratory morbidity and mortality in preterm infants. Data on its
haemodynamic consequences are conflicting. The aim was to characterise the haemodynamic effects of surfactant
treatment on cardiac function in preterm newborns with respiratory distress syndrome (RDS).
Methods: Preterm infants (gestational age <34 weeks, birth weight <2000 g) with RDS, who received surfactant
within 72 hours of life, were recruited.
Echocardiography was performed before surfactant, and 2 and 24 hours after. Left and right ventricular peak
systolic, early diastolic and late diastolic myocardial velocities were measured using Tissue Doppler Imaging (TDI),
while characteristics of the ductus arteriosus, pulmonary artery pressure, right ventricular (RVO) and left ventricular
output were measured by standard echocardiography. Tricuspidal Annular Plane Systolic Excursion (TAPSE) was
measured on the free wall of the tricuspid annulus.
Results: Fourteen patients were studied. Surfactant was associated with a decrease in pulmonary pressure and an
increase in RVO. The improvement of right ventricular function was also confirmed by a significant increase in right
peak systolic velocity and in TAPSE. Left ventricular velocities did not change significantly after surfactant.
Conclusions: Surfactant administration in preterm infants with RDS did not impair myocardial contractility and was
followed by increased RVO, in agreement with other parameters of right ventricular function. TDI and TAPSE
appeared to be reliable and feasible in this population. The addition of TDI and TAPSE to standard neonatal
echocardiography may provide additional information about cardiac function.
Keywords: Echocardiography, Preterm infant, Surfactant, Tissue doppler imaging, Tricuspidal annular plane systolic
excursionBackground
Respiratory distress syndrome (RDS) represents one of
the major causes of neonatal morbidity and mortality in
preterm infants [1]. Moderate and even severe RDS are
increasingly being treated with nCPAP and surfactant
administration using the “InSurE” procedure (Intubation,
Surfactant, Extubation) rather than with mechanical venti-
lation [2]. Treatment with surfactant improves oxygenation* Correspondence: silvia.galletti4@unibo.it
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unless otherwise stated.and lung compliance [3]. The reduction in pulmonary vas-
cular resistance following surfactant administration may
increase pulmonary blood flow [4-6]. In the presence of a
patent ductus arteriosus (PDA) and a large systemic-to-
pulmonary pressure gradient, systemic blood flow and
end-organ perfusion may fall substantially [4-9]. Data on
the haemodynamic consequences of surfactant adminis-
tration are conflicting [10-12]. It has been shown that sur-
factant administration can be associated with changes in
brain haemodynamics, which may contribute to the devel-
opment of intracranial haemorrhage and periventricular
leukomalacia, but the mechanism by which this occurs is
still unclear [10,13]. Furthermore, it has been shown ind. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ated with a low diastolic arterial pressure; the conse-
quences of this change is unknown, but possible effects
include compromised coronary artery perfusion leading to
myocardial fatigue and low cardiac output [10].
Previous studies have investigated cardiac function after
surfactant therapy in preterm infants using standard ultra-
sound methods. These methods have several limitations in
preterm newborns, because cardiac function is affected by
heart rate, preload and afterload, which are extremely vari-
able during the first days of life. Pulmonary artery pressure
(PAP) can also be assessed non-invasively using Doppler
echocardiography [14]. Tissue Doppler Imaging (TDI) is a
relatively new echocardiographic technique which pro-
vides velocities of the myocardial wall during the cardiac
cycle; it allows the quantification of both regional and glo-
bal systolic and diastolic function and has the advantage
over pulse-wave Doppler (PWD) of being less dependent
on preload and afterload than standard echocardiography
(ECHO) [12,15-18].
The Tricuspid Annular Plane Systolic Excursion (TAPSE)
is an echocardiographic measurement which assesses right
ventricular systolic function in a simple, repeatable, and
highly reproducible way. Until recently, TAPSE was not
part of routine echocardiographic assessment in neonatal
care: normal values for preterm and term neonates, with
respect to gestational age and birth weight, have been pro-
posed only in 2011 [19].
An improved understanding of the haemodynamic
consequences of surfactant administration using new
echocardiographic techniques may further enhance our
clinical approach to the preterm population.
For this reason, the aim of the present study was to
characterise the haemodynamic effects of surfactant
treatment on cardiac function in preterm newborns with
respiratory distress syndrome (RDS), comparing stand-
ard ultrasound methods with ECHO measures recently
applied to assess cardiac function in preterm infants,
such as TAPSE and TDI.
Methods
Study population
This prospective, pilot study was conducted between
December 2011 and May 2012. Preterm infants con-
secutively admitted to the Neonatal Intensive Care Unit
(NICU) at S.Orsola-Malpighi Hospital - Bologna, who
satisfied the following criteria were included in the
study:
– Birth weight <2000 g;
– Gestational age 26-34 weeks;
– Moderate to severe RDS, treated with selective
endotracheal surfactant replacement with the
InSurE procedure within 72 hours of life.Exclusion criteria were the following:
– Congenital heart disease (CHD), other than PDA
and patent foramen ovale (PFO);
– Major congenital malformations;
– Sepsis;
– Need for mechanical ventilation.
Study design
According to the guidelines for the management of RDS
in our NICU, on admission all the infants received non-
invasive respiratory support with nCPAP. They were
then intubated, given surfactant and extubated. Two-
dimensional ECHO was performed before surfactant ad-
ministration (T0), and 2 (T1) and 24 hours (T2) after.
Timing of surfactant administration ranged from 1 to
72 hours of life.
The study protocol was approved by the Institutional
Ethics Committee of S.Orsola-Malpighi Hospital, Bologna.
Written informed consent was obtained from each patient
parent/guardian.
InSurE procedure
Before intubation, infants received a single i.v. bolus of
fentanyl (1 mcg/kg) and, when necessary, they were
briefly ventilated with bag and mask and additional oxy-
gen to maintain SpO2 values between 85 and 94%. After
intubation, surfactant (Curosurf 200 mg/kg; Chiesi
Farmaceutici SpA, Parma, Italy) was given endotrache-
ally, and the administration was followed by manual ven-
tilation through the endotracheal tube for 2-5 minutes.
When good respiratory drive and satisfactory transcutane-
ous oxygen saturation (SpO2 ≥ 85% with FiO2 ≤ 30%)
values were established, infants were extubated and
nCPAP was restarted using a CPAP level equal or 0.5
cmH2O lower than the one required before the procedure.
Echocardiographic measurements
The ECHOs were performed using a Philips HD11XE
System (Philips Ultrasound, Andover, MA, USA) with a
S12-4 Hz transducer. A single operator performed all the
ECHO scans. Post processing analysis was performed after
the scan.
Using ECHO, ductal characteristics, pulmonary artery
pressure, mitral flow velocity, ventricular output for both
ventricles and myocardial wall velocities were evaluated.
CHD other than PDA or PFO were excluded by the T0
scan.
All measurements were taken repeatedly over three to
five consecutive cardiac cycles to minimise variations re-
lated to the respiratory cycle; the mean value for each
ECHO measurement was used for the analysis. For Dop-
pler evaluations, images were optimised to ensure that
Table 1 Characteristics of the patients included in the study
Gender (M/F) 11/3
Congenital heart disease 0/14
Gestational age (weeks); median, IQR 30, 27.5-33.4
Birth weight (grams); median, IQR 1162, 500-1990
nCPAP requirement on admission 14/14
Pressure (cmH2O); median, range 4, 3.5-5
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order to minimise flow underestimation.
Standard ECHO
The ductus arteriosus was evaluated from a suprasternal
notch view using a combination of two-dimensional and
colour Doppler echocardiography [20]. If PDA was
present, the transductal diameter was calculated with
two dimensional ECHO. Then, the pulsed Doppler gate
was carefully placed in the pulmonary end of the ductus
and the flow pattern of the shunt was recorded. Three
Doppler patterns were identified: pulsatile or unrestric-
tive, bidirectional and restrictive.
Using a parasternal long axis view, 2D M-mode mea-
surements were performed to obtain the left atrium to
aortic root ratio (LA:Ao). TAPSE was measured using an
apical four chamber view with the cursor placed on the
free wall of the tricuspid annulus [21]. Maximal TAPSE
was determined by the total excursion of the tricuspid
annulus from its highest position after atrial ascent to
the lowest point of descent during ventricular systole.
From the same view, mitral inflow velocities were also
obtained by a PWD sample gate at the valve leaflet tip.
Offline analysis was used to calculate early diastolic flow
velocity (E), late diastolic flow velocity (A) and their ra-
tio (E/A).
Left ventricular output (LVO) was calculated according to
the formula [(left ventricular outflow velocity time integral)
[VTI] × (heart rate) × (left ventricular outflow cross-
sectional area)], and indexed to body weight. The left ven-
tricular outflow diameter was measured using a parasternal
long axis view using the leading edge technique [22]. VTI
was estimated from an apical five-chamber view with the
sample volume placed in the left ventricular outflow tract.
Right ventricular output (RVO) was evaluated from an
oblique long axis view and calculated according to the for-
mula [(right ventricular outflow VTI) × (heart rate) × (right
ventricular outflow cross-sectional area)], indexed to
body weight. Both left and right VTIs were calculated
using the average of five consecutive cardiac cycles to
minimise variations related to the respiratory cycle [22].
Pulmonary artery pressure (PAP) was calculated using
the ratio of the acceleration time (AT) to right ventricular
ejection time (RVET). AT/RVET correlates inversely with
PAP [14]. AT refers to the time interval from the begin-
ning of ventricular systole to the achievement of peak
velocity, while ET to the time interval from the beginning
to the end of ventricular systole. AT and RVET measure-
ments were made with the Doppler velocity waveform.
The values above were obtained with a minimum of five
consecutive waveforms. Because mean AT/RVET did not
correlate significantly with the R–R interval at the ECG,
we decided to not perform correction of AT/RVET for
the heart rate as described in other papers [23,24].TDI analysis
Myocardial velocities were obtained using an apical
four-chamber view and were measured at the basal seg-
ments. Pulsed-wave TDI was performed by adjusting the
spectral pulsed Doppler signal filters to obtain a Nyquist
limit of 15–20 cm/s. High-frame-rate (150 frames/s) im-
ages were acquired in the tissue Doppler mode. A PWD
sample gate of 0.12 cm was positioned at the lateral tri-
cuspid and mitral annuli (LTA and LMA, respectively)
to acquire right and left ventricular velocities. Peak sys-
tolic (S’), early diastolic (E’) and late diastolic (A’) myo-
cardial velocities were measured for each ventricle. E/E’
ratio was calculated for the left ventricle.
Statistical analysis
Data were analysed using SPSS 16.0 for Windows (Stat-
istical Package for Social Sciences, SPSS Inc., Chicago,
Ill, US). Data were not normally distributed, thus non
parametric statistical methods were used. Differences be-
tween ECHO measures taken at T0, T1 and T2 were
evaluated by Wilcoxon Signed Ranks Test. The relation-
ship between left ventricle E and E’ at T0, T1 and T2
were evaluated by Spearman Test. A p value < 0.05 was
considered as statistically significant.
Similarly to previous studies [16], intra-observer re-
producibility was evaluated by calculating coefficient of
variations (CVs), expressed as (standard deviation/arith-
metic mean of measurements) × 100.
Results
Clinical data
The characteristics of the patients are detailed in Table 1.
Over the study period, all the infants had normal heart
rate (range, 125-168 bpm) and normal blood pressure;
none of them required inotrope support.
Standard ECHO data
The characteristics of PDA at T0 are detailed in Table 2.
At T1, mean TDD and transductal blood flow did not
change significantly. At T1, a non-significant increase in
LA:Ao was detected, compared to T0 (p = 0.085).
At T2, transductal blood flow was exclusively left to
right in 9/14 patients. Ductus arteriosus was found to be
closed in 2/14 infants. In the remaining 3 patients,
ductal blood flow had not changed.
Table 2 Characteristics of patent ductus arteriosus
Presence of patent ductus arteriosus @ T0 14/14
Transductal diameter @ T0 (mm); mean, SD 2.1, 0.3
Exclusive left-to-right transductal blood flow @ T0 8/14
Presence of right-to-left transductal blood flow @ T0 6/14
Proportion of right-to-left transductal blood
flow @ T0; median, range
25.5%, 24-28
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difference was detected in transmitralic E and A at T1
and T2, compared to T0. There was no change in trans-
mitralic E/A ratios over time. In 13 patients the AT/
RVET ratio increased significantly at T2 compared to
T0. There was no increase in the AT/RVET ratio only in
the patient who developed a pneumothorax after surfac-
tant administration.
Compared to T0, TAPSE was not significantly different at
T1, but increased significantly at T2. RVO at T2 was signifi-
cantly higher than at T0. There was no significant dif-
ference in RVO between T1 and T2. LVO at T2 was
significantly higher than at T0. No difference in LVO be-
tween T0 and T1, or between T1 and T2 was documented.
TDI data
In all the infants myocardial velocities were higher in the
right ventricle than in the left ventricle. In the leftTable 3 Echocardiographic parameters measured before the a
24 hours (T2) after
T0 T1
AT/RVET 0.25 ± 0.05 0.30 ± 0.06
Left ventricle
E (cm/sec) 40.84 ± 11.84 40.24 ± 4.63
A (cm/sec) 51.13 ± 14.98 49.47 ± 7.79
E/A 0.81 ± 0.13 0.83 ± 0.13
LVO (ml/Kg/min) 204.13 ± 65.24 210.89 ± 76.42
RVO (ml/Kg/min) 220.82 ± 95.57 265.08 ± 65.88
Left ventricle
S’ 3.26 ± 0.51 3.50 ± 0.64
E’ 4.75 ± 1.01 4.59 ± 0.77
A’ 4.16 ± 1.13 4.56 ± 1.57
Right ventricle
S’ 4.64 ± 0.75 4.60 ± 1.05
E’ 5.47 ± 1.12 5.67 ± 1.12
A’ 6.88 ± 1.37 7.08 ± 1.78
Left ventricle
E/E’ 8.77 ± 2.46 8.98 ± 1.60
TAPSE (cm) 0.72 ± 0.17 0.73 ± 0.12
Data are presented as mean ± SD. Significant p values are reported in bold.
AT: acceleration time; RVET: right ventricular ejection time; LVO: left ventricular output;ventricle S’, E’ and A’ velocities, as well as the left ven-
tricle E/E’ ratio, at T1 and T2 were not significantly dif-
ferent from those detected at T0. There was no
significant difference in right S’ at 2 hours after surfac-
tant administration; however, a significant increase was
detected 24 hours after surfactant therapy. The right E’
and A’ velocities did not change significantly at 2 and
24 hours.
There was a significant correlation between left ven-
tricle E and E’ at T2 (ρ = 0.6; p = 0.025), but not at T0
(ρ = 0.5; p = 0.06) and T1 (ρ = 0.25; p = 0.5).
Intra-observer reproducibility was low: for example,
the median CV for TAPSE at T0 was 3.7% (interquartile
range 0.92-8.9), while for left ventricle S’ velocity at T0
was 3.9% (interquartile range 3.4-8.3).Discussion
This pilot study is the first attempt to evaluate haemo-
dynamic changes after surfactant administration using
new echocardiographic techniques. We observed that,
after the administration of surfactant, the AT/RVET ra-
tio increased over time, and this increase became statis-
tically significant at 24 hours compared to baseline. The
increase in the AT/RVET was inversely correlated to
pulmonary pressure, and the decrease in pulmonary pres-
sure was associated with an increase in RVO, documenteddministration of surfactant (T0), and 2 hours (T1) and
T2 p value p value p value
T0 vs T1 T0 vs T2 T1 vs T2
0.33 ± 0.06 0.066 0.001 0.011
45.85 ± 15.56 0.953 0.272 0.374
52.12 ± 14.2 0.260 0.925 0.260
0.88 ± 0.17 0.192 0.300 0.314
227.91 ± 77.41 0.779 0.041 0.327
256.86 ± 113.09 0.674 0.050 0.889
3.52 ± 0.67 0.085 0.372 0.953
5.02 ± 1.54 0.406 0.593 0.086
5.05 ± 2.04 0.314 0.124 0.260
5.27 ± 0.87 0.859 0.035 0.260
6.24 ± 1.69 0.214 0.198 0.515
7.48 ± 0.97 0.678 0.272 0.374
9.48 ± 3.06 0.953 0.509 0.767
0.85 ± 0.13 0.767 0.002 0.008
RVO: right ventricular output; TAPSE: Tricuspidal Annular Plane Systolic Excursion.
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in PAP using Doppler measuring AT/RVET ratio in pre-
term after surfactant therapy. However, although the AT/
RVET correlates with PAP, it can also be influenced by
myocardial contractility [25].
The increase in RVO which followed the administra-
tion of surfactant could be due to a concomitant de-
crease in right ventricular afterload or to the maturation
of the myocardial tissue after birth.
A significant increase in right peak systolic velocity and
in TAPSE was documented at T2. Recently, Koestenberger
et al. established normal reference values of TAPSE in
preterm and term newborns [26]. In our study, data ob-
tained in a more selected population of preterm infants
with RDS confirmed that changes in TAPSE were in line
with other parameters of right ventricular function. Thus,
TAPSE can be considered as a reliable measure of right
ventricular function also in preterm infants with nCPAP
respiratory support in the first days of life and after surfac-
tant therapy. These findings can be important for neonatal
clinical practice, because TAPSE reproducibility is higher
than that of other ECHO indices of right function. Fur-
thermore, TAPSE is independent from heart rate varia-
tions [26].
With regard to LVO, no difference was documented in
our patients at 2 hours compared to baseline; however, a
significant increase in LVO was found after 24 hours
from surfactant administration.
Previous data regarding the impact of surfactant ad-
ministration on haemodynamics in preterm infants are
conflicting. Some studies have shown that surfactant de-
termined a fall in pulmonary pressure which was
followed by an increase in transductal shunt [8], with a
consequent reduction in RVO and an increase in LVO
due to preload augmentation [4-6]. On the other side,
Sehgal et al. studied the early consequences of surfactant
administration in the delivery room, showing that giving
surfactant within 30 minutes of birth was associated
with an increase in the ductal size, a predominant left-
to-right transductal flow, an increase in RVO and a de-
crease in LVO [10]. The authors hypothesized that this
was due to an augmentation of right ventricular inflow
via increased left-to-right transatrial flow, because the
size of the foramen ovale is maximum immediately after
birth. We can speculate that the lack of LVO increase
observed in our patients at T1 could be due to the left-
to-right flow across the foramen ovale. The significant
increase of LVO at T2 could be explained instead by sev-
eral reasons, including the changing flow across the
ductus arteriosus, the adaptation of the left ventricle to
the increase in afterload and the change in peripheral
vascular resistance.
In the study by Sehgal et al., surfactant administration
was followed by an early low diastolic arterial pressure[10]: the authors suggested that this could compromise
coronary artery perfusion and lower cardiac output. In
our study, TDI examination showed that both right and
left myocardial velocities did not change after surfactant
administration, except for right peak systolic velocity,
which improved; thus, according to our data, it seems
unlikely that surfactant can compromise myocardial
perfusion.
TDI feasibility in preterm and term infants was re-
cently demonstrated in some studies [12,16,17], but the
applicability of TDI in neonatal clinical practice still
needs to be defined. Similarly to Negrine et al. [15], our
data, obtained in a more selected and homogeneous
population, show that peak velocities in the right ven-
tricle are higher than in the left ventricle.
This study presents several limitations: the number of
included infants is small, and the range of gestational
age and birth weight is quite wide; furthermore, a single
operator performed all the scans, and it was not possible
to calculate the interobserver variability, especially for
TDI.
In conclusion, we observed that after surfactant ad-
ministration TAPSE significantly increased over time in
agreement with other parameters of right ventricular
function such as AT/RVET and RVO; thus the use of
TAPSE in this population appears to be reliable. More-
over, TDI data suggest that surfactant administration in
preterm infants with RDS did not impair myocardial
function. These observations encourage the development
of further studies investigating the role of TDI and
TAPSE in the neonatal population.Abbreviations
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